The Quality Standards Resource Centre helps extend understanding of the strengthened Aged Care Quality Standards, which took effect from 1 November 2025. You can search for resources by using keywords, or filtering by standard, outcome and audience. Before using the Resource Centre, please read the terms of use.
Documentation of patient information
This resource outlines best practices for documenting patient information related to medication history and adverse drug reactions. It provides guidance on obtaining the best possible medication history (BPMH), reconciling medications at care transitions, and recording known allergies. The resource helps aged care providers ensure accurate medication management, reduce errors, and prevent harm from adverse drug events.
This resource may apply to healthcare contexts outside of aged care. Please consider the applicability of this resource to your care setting.
Guide for consumers - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard
This resource is a guide for consumers about the Australian Commission on Safety and Quality in Health Care's Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard. The resource includes 8 quality statements about the health care consumers should receive to support the correct use of psychotropic medicines.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Polypharmacy Consumer Perspective - National Medicines Symposium 2024
This is a presentation on Polypharmacy Consumer Perspective. It includes details of a case example, resolution and care management, and key principles related to medicines and goal of care. This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Case study - Safe and Appropriate use of Psychotropic Medicines - Residential Aged Care
This resource is a fictional scenario that follows an older person’s care pathway with a residential aged care provider. The resource focuses on the systems and processes to support high-quality care of older people living with cognitive impairment. It includes 4 key priority areas: person-centred care, medication management, managing changed behaviours and transitions of care.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Case study - Safe and Appropriate use of Psychotropic Medicines - In-home Aged Care
This resource is a fictional scenario that follows an older person’s care pathway with an in-home aged care provider. The resource focuses on the systems and processes to support high-quality care of older people living with dementia. It includes 4 key priority areas: person-centred care, medication management, managing changed behaviours and transitions of care.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Safe and appropriate use of psychotropic medicines for aged care - Fact sheet
This fact sheet is informed by the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (CCS), developed by the Australian Commission on Safety and Quality in Health Care. The CCS describes the safe and appropriate use of psychotropic medicines for people with cognitive disability or impairment, in a way that upholds their rights, dignity, health and quality of life.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
